The main positive, which is a big one, is the huge turnaround in shareholder equity. It’s been a remarkable turnaround in a 12 month period. I think the best people to read these documents are financial professionals. I try to read it as I would the financials for my own small company. 3 years ago- Generex wasn’t even current with their SEC filings. So, a really great job of righting the ship, but of course she needs to keep sailing in the right direction towards an eventual uplist.
(0)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links